Literature DB >> 26991343

A preliminary microarray assay of the miRNA expression signatures in buccal mucosa of oral submucous fibrosis patients.

Daminee Chickooree1, Keke Zhu1, Vahsish Ram2, Han Jiang Wu1, Zhi Jing He1, Sheng Zhang3.   

Abstract

OBJECTIVES: The objectives of this study are threefold: First is to perform a preliminary microarray analysis of miRNA expression profile to filter out differentially expressed miRNA in oral submucous fibrosis, second is to perform a bioinformatics analysis to identify miRNA-specific predicted genes, and third to retrieve those miRNAs from literature and account for the findings of our investigations.
METHODS: Buccal mucosa samples from three clinically evident OSF patients and three normal volunteers were collected. Agilent Human miRNA microarray experiments were carried out to analyze the miRNA expression profile in both OSF and normal tissues. To identify molecular pathways potentially altered by expression of miRNAs, DAVID software was used. This application performs an enrichment analysis of multiple miRNA target genes comparing each set of miRNA targets to known KEGG pathway.
RESULTS: A total of 11 unique miRNAs were differentially expressed. The overexpressed miRNAs were hsa-miR-455-3p, hsa-miR-455-5p, and hsa-miR-623, and underexpressed miRNAs were hsa-miR-1290, hsa-miR-3180-3p, hsa-miR-4792, hsa-miR-509-3-5p, hsa-miR-5189, hsa-miR-610, hsa-miR-760, and hsa-miR-921. Six miRNAs namely miR-455, miR-760, miR-623, miR-610 and miR-509-3-5p were selected.
CONCLUSION: This study shows that miRNA chip can be used for high-throughput screening of miRNA. Target prediction and annotation of the miRNAs demonstrated that the binding, metabolic process, molecular, and cellular process are the most common functions of the predicted targets of these newly identified miRNAs.
© 2016 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  bioinformatics; microRNA; microarray analysis; oral precancer; submucous fibrosis

Mesh:

Substances:

Year:  2016        PMID: 26991343     DOI: 10.1111/jop.12431

Source DB:  PubMed          Journal:  J Oral Pathol Med        ISSN: 0904-2512            Impact factor:   4.253


  17 in total

Review 1.  MiR-1290: a potential therapeutic target for regenerative medicine or diagnosis and treatment of non-malignant diseases.

Authors:  Mohammad Reza Kalhori; Masoud Soleimani; Kheirollah Yari; Mahmoudreza Moradi; Amir Ali Kalhori
Journal:  Clin Exp Med       Date:  2022-07-08       Impact factor: 3.984

2.  Knockdown of LncRNA NEAT1 inhibits myofibroblast activity in oral submucous fibrosis through miR-760/TPM1 axis.

Authors:  Wei Li; Bin Cheng
Journal:  J Dent Sci       Date:  2021-12-08       Impact factor: 3.719

3.  Identification of the Pathogenic Biomarkers for Hepatocellular Carcinoma Based on RNA-seq Analyses.

Authors:  Wentao Jiang; Li Zhang; Qingjun Guo; Honghai Wang; Ming Ma; Jisan Sun; Chiyi Chen
Journal:  Pathol Oncol Res       Date:  2019-01-24       Impact factor: 3.201

4.  Circulating miR-455-3p, miR-5787, and miR-548a-3p as potential noninvasive biomarkers in the diagnosis of acute graft-versus-host disease: a validation study.

Authors:  Jamshid Motaei; Mohammad Amin Kerachian; Seied Asadollah Mousavi; Kamran Alimoghadam; Ardeshir Ghavamzadeh; Saba Manoochehrabadi; Mohammad Ahmadvand; Marjan Yaghmaie
Journal:  Ann Hematol       Date:  2021-07-11       Impact factor: 3.673

5.  MicroRNA-1291 promotes endometrial fibrosis by regulating the ArhGAP29-RhoA/ROCK1 signaling pathway in a murine model.

Authors:  Qian Xu; Hua Duan; Lu Gan; Xin Liu; Fang Chen; Xue Shen; Yi-Qun Tang; Sha Wang
Journal:  Mol Med Rep       Date:  2017-08-10       Impact factor: 2.952

6.  Small non-coding RNA profiling in human biofluids and surrogate tissues from healthy individuals: description of the diverse and most represented species.

Authors:  Giulio Ferrero; Francesca Cordero; Sonia Tarallo; Maddalena Arigoni; Federica Riccardo; Gaetano Gallo; Guglielmo Ronco; Marco Allasia; Neha Kulkarni; Giuseppe Matullo; Paolo Vineis; Raffaele A Calogero; Barbara Pardini; Alessio Naccarati
Journal:  Oncotarget       Date:  2017-12-14

7.  MicroRNA-610 inhibits tumor growth of melanoma by targeting LRP6.

Authors:  Guangjing Zhang; Dongfang Ai; Xiufang Yang; Shanshan Ji; Zhengxiang Wang; Shijun Feng
Journal:  Oncotarget       Date:  2017-10-26

Review 8.  MicroRNA's - The vibrant performers in the oral cancer scenario.

Authors:  Monica Charlotte Solomon; Raghu Anekal Radhakrishnan
Journal:  Jpn Dent Sci Rev       Date:  2020-05-20

9.  Adipose-Derived Stem Cell-Derived Extracellular Vesicles Inhibit the Fibrosis of Fibrotic Buccal Mucosal Fibroblasts via the MicroRNA-375/FOXF1 Axis.

Authors:  Bin Han; Yanhui Zhang; Yuxia Xiao; Bohong Shi; Hong Wu; Desheng Liu
Journal:  Stem Cells Int       Date:  2021-06-22       Impact factor: 5.443

10.  microRNAs expression profile related with response to preoperative radiochemotherapy in patients with locally advanced gastric cancer.

Authors:  Xiaowen Liu; Hong Cai; Weiqi Sheng; Hua Huang; Ziwen Long; Yanong Wang
Journal:  BMC Cancer       Date:  2018-10-29       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.